Stock Events

Stock Events

Acro Biomedical 

$0.026000
2
-$0.00-0% Friday 20:00

Statistics

Day High
0.026
Day Low
0.026
52W High
0.1
52W Low
0.0007
Volume
66
Avg. Volume
6
Mkt Cap
1.56M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

21NovExpected
Q1 2021
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.07
-0.05
-0.03
-0.02
Expected EPS
N/A
Actual EPS
-0.07

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-101,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap655.92M
MiMedx Group Inc. specializes in regenerative biomaterials, similar to ACBM's focus on collagen-based products for medical applications.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences manufactures surgical implants and medical instruments, competing in the regenerative product market like ACBM.
Bio-Techne
TECH
Mkt Cap11.35B
Bio-Techne Corporation produces biotechnology products and clinical calibrators, aligning with ACBM's biotech focus.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew plc manufactures medical equipment, including advanced wound management products, competing in similar spaces as ACBM.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. specializes in musculoskeletal healthcare, which can include the use of collagen products like those of ACBM.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a leader in medical technology, including regenerative and reconstructive products, competing with ACBM's niche.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson engages in the development of biomedicals and surgical products, overlapping with ACBM's market interests.

About

Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
Show more...
CEO
Yu-Ting Su
Employees
1
Country
United States
ISIN
US0048921052

Listings

TWO
TW
6748.TWO
OTC Link
US
ACBM

0 Comments

Share your thoughts

FAQ

What is Acro Biomedical stock price today?▼
The current price of ACBM is $0.03 USD — it has decreased by -0% in the past 24 hours. Watch Acro Biomedical stock price performance more closely on the chart.
What is Acro Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Acro Biomedical stocks are traded under the ticker ACBM.
Is Acro Biomedical stock price growing?▼
ACBM stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Acro Biomedical has showed a +3,614.29% increase.
What is Acro Biomedical market cap?▼
Today Acro Biomedical has the market capitalization of 1.56M
What were Acro Biomedical earnings last quarter?▼
ACBM earnings for the last quarter are -0.07 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Acro Biomedical revenue for the last year?▼
Acro Biomedical revenue for the last year amounts to 0 USD.
What is Acro Biomedical net income for the last year?▼
ACBM net income for the last year is -101,000 USD.
How many employees does Acro Biomedical have?▼
As of September 04, 2026, the company has 1 employees.
In which sector is Acro Biomedical located?▼
Acro Biomedical operates in the Health & Wellness sector.
When did Acro Biomedical complete a stock split?▼
The last stock split for Acro Biomedical was on May 22, 2017 with a ratio of 3:1.
Where is Acro Biomedical headquartered?▼
Acro Biomedical is headquartered in Fishers, United States.